Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4550

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-4550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Atorvastatin Calcium tablets in 10 mg strength with a quantity of 100 tablets. The tablets are white, oval-shaped, and marked with "10" and "A53." The medication is repackaged by RemedyRepack Inc. with manufacturing details provided for Camber Pharma, Inc. It is a prescription drug and the usual dosage instructions are recommended to be found in the insert. The storage instructions advise keeping the medication at a temperature between 20-25°C (68-77°F) with permissible excursions to 15-30°C (59-86°F).*

FDA Label Image

Atorvachemicalstructure (Atorvachemicalstructure)

FDA Label Image

Atorvafigure1 (Atorvafigure1)

This is a statistical comparison of the cumulative incidence (%) between Atorvastatin and Placebo over a 35-year period. The Hazard Ratio (HR) is 0.64 with a confidence interval of 0.50-0.83 and a significant p-value of 0.0005, indicating a difference in incidence rates between the two groups.*

FDA Label Image

Atorvafigure2 (Atorvafigure2)

This text provides information on the cumulative hazard (%) at various percentages, specifically related to the drug Atorvastatin. It includes hazard ratios, confidence intervals, and p-values for the drug's effect. Additionally, it mentions the time to the first primary endpoint over a four-year follow-up period.*

FDA Label Image

Atorvafigure3 (Atorvafigure3)

This text provides data on the percentage of subjects experiencing an event, the comparison between two doses of Atorvastatin (10 mg and 80 mg), hazard ratio (HR) with confidence interval and p-value, as well as the time to the first major cardiovascular endpoint in years.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.